订阅小程序
旧版功能

Discovery of CBPD-409 and CBPD-268 As Highly Potent and Orally Efficacious CBP/p300 PROTAC Degraders for the Treatment of Castration-Resistant Prostate Cancer

Cancer Research(2024)

引用 0|浏览45
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要